Related references
Note: Only part of the references are listed.Desmin Mutations and Arrhythmogenic Right Ventricular Cardiomyopathy
Alessandra Lorenzon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Homozygous Founder Mutation in Desmocollin-2 (DSC2) Causes Arrhythmogenic Cardiomyopathy in the Hutterite Population
Brenda Gerull et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes
Silvia G. Priori et al.
EUROPACE (2013)
Mutations in the area composita protein T-catenin are associated with arrhythmogenic right ventricular cardiomyopathy
Jolanda van Hengel et al.
EUROPEAN HEART JOURNAL (2013)
Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
Revathi Rajkumar et al.
BMC MEDICAL GENETICS (2012)
Abnormal Termination of Ca2+ Release Is a Common Defect of RyR2 Mutations Associated With Cardiomyopathies
Yijun Tang et al.
CIRCULATION RESEARCH (2012)
Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy
Giovanni Quarta et al.
EUROPEAN HEART JOURNAL (2012)
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy
Paul A. van der Zwaag et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Arrhythmogenic right ventricular cardiomyopathy/dysplasia and troponin release. Myocarditis or the hot phase of the disease?
A. P. Patrianakos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Desmosome-Ion Channel Interactions and Their Possible Role in Arrhythmogenic Cardiomyopathy
Mario Delmar
PEDIATRIC CARDIOLOGY (2012)
Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy-Overlap Syndromes
Matthew Taylor et al.
CIRCULATION (2011)
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Michael J. Ackerman et al.
EUROPACE (2011)
Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks
Ellen Otten et al.
HEART RHYTHM (2010)
A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
Fatima Djouadi et al.
CARDIOVASCULAR RESEARCH (2009)
A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy.
Angeliki Asimaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene
Nancy D. Merner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations
Rosy Joshi-Mukherjee et al.
HEART RHYTHM (2008)
The sarcoplasmic reticulum and arrhythmogenic calcium release
Luigi A. Venetucci et al.
CARDIOVASCULAR RESEARCH (2008)
A novel dominant mutation in plakoglobin causes Arrhythmogenic right ventricular cardiomyopathy
Angeliki Asimaki et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells
Eva M. Oxford et al.
CIRCULATION RESEARCH (2007)
Remodeling of gap junctions in ischemic and nonischemic forms of heart disease
Jeffrey E. Saffitz et al.
JOURNAL OF MEMBRANE BIOLOGY (2007)
Giant cell myocarditis and arrhythmogenic right ventricular dysplasia
Jaime Aguero et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2007)
Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies
Harald Bar et al.
HUMAN MUTATION (2007)
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis
Antonio Pelliccia et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2006)
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy
Arnd Heuser et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice
Paulus Kirchhof et al.
CIRCULATION (2006)
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
Eduardo Garcia-Gras et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy
K Pilichou et al.
CIRCULATION (2006)
Activation of peroxisome proliferator-activated receptor-α and -γ in auricular tissue from heart failure patients
D Gómez-Garre et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses?
F Calabrese et al.
CARDIOVASCULAR PATHOLOGY (2006)
Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy
K Yamaji et al.
ACTA CARDIOLOGICA (2005)
Postnatal isl1+cardioblasts enter fully differentiated cardiomyocyte lineages
KL Laugwitz et al.
NATURE (2005)
Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1
G Beffagna et al.
CARDIOVASCULAR RESEARCH (2005)
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy
B Gerull et al.
NATURE GENETICS (2004)
Structural and molecular pathology of the heart in Carvajal syndrome
SR Kaplan et al.
CARDIOVASCULAR PATHOLOGY (2004)
A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy:: Modulation by dietary fat content
BN Finck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Quantitative analysis of peroxisome proliferator-activated receptor gamma (PPAR gamma) expression in arteries and hearts of patients with ischaemic or dilated cardiomyopathy
MR Mehrabi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy
A Rampazzo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors
KA Longo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart
BN Finck et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Genetics of arrhythmogenic right ventricular cardiomyopathy
GA Danieli et al.
CURRENT OPINION IN CARDIOLOGY (2002)
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
N Tiso et al.
HUMAN MOLECULAR GENETICS (2001)
Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma
EE Norgett et al.
HUMAN MOLECULAR GENETICS (2000)
PPAR signaling in the control of cardiac energy metabolism
PM Barger et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2000)
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
G McKoy et al.
LANCET (2000)
Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2
S Hakimelahi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy
F Calabrese et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy
G Thiene et al.
HERZ (2000)
Chronic right-sided myocarditis mimicking arrhythmogenic right ventricular dysplasia
PJ Michaels et al.
HUMAN PATHOLOGY (2000)
Wnt-1 regulation of connexin43 in cardiac myocytes
ZW Ai et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
